David Livermore (microbiologist): Difference between revisions
Content deleted Content added
Philafrenzy (talk | contribs) |
expansion |
||
| Line 1: | Line 1: | ||
{{Under construction|date=October 2020}} |
{{Under construction|date=October 2020}} |
||
'''David Livermore''' is professor of medical microbiology at the University of East Anglia.<ref>{{cite news |last=Livermore |first=David |date=10 October 2020 |title=Protect the elderly, but let's see life back to normal for those at low risk |url=https://www.telegraph.co.uk/opinion/2020/10/10/protect-elderly-see-life-back-normal-low-risk/ |work=[[Daily Telegraph]] |location= |access-date=11 October 2020}} </ref> |
'''David Livermore''' is professor of medical microbiology at the University of East Anglia.<ref>{{cite news |last=Livermore |first=David |date=10 October 2020 |title=Protect the elderly, but let's see life back to normal for those at low risk |url=https://www.telegraph.co.uk/opinion/2020/10/10/protect-elderly-see-life-back-normal-low-risk/ |work=[[Daily Telegraph]] |location= |access-date=11 October 2020}} </ref> |
||
After working at the [[London Hospital Medical College]] from 1980 to 1997, he joined the [[Public Health Laboratory Service]] (later PHE), and became director of its Antibiotic Resistance Monitoring and Reference Laboratory. He was appointed professor of medical microbiology at the University of East Anglia in 2011. His chief research has been on the evolution and epidemiology of [[antibiotic resistance]].<ref name=BSAC>{{Cite web|title=Professor David Livermore|url=http://bsac.org.uk/speakers/professor-david-livermore/|access-date=11 October 2020|website=British Society for Antimicrobial Chemotherapy|language=en}}</ref><ref name=Rumbaugh>{{Cite book|last=Rumbaugh|first=Kendra P.|url=https://books.google.co.uk/books?id=mZqKAwAAQBAJ&pg=PA473&dq=David+Livermore+antibiotics&hl=en&sa=X&ved=2ahUKEwjy9rrLqazsAhUHZMAKHSvsDTIQ6AEwAXoECAQQAg#v=onepage&q=David%20Livermore%20antibiotics&f=false|title=Antibiofilm Agents: From Diagnosis to Treatment and Prevention|last2=Ahmad|first2=Iqbal|date=2014|publisher=Springer Science & Business Media|year=|isbn=978-3-642-53832-2|location=|pages=473|language=en}}</ref> |
|||
== References == |
== References == |
||
Revision as of 10:45, 11 October 2020
 | This article or section is in a state of significant expansion or restructuring. You are welcome to assist in its construction by editing it as well. If this article or section has not been edited in several days, please remove this template. If you are the editor who added this template and you are actively editing, please be sure to replace this template with {{in use}} during the active editing session. Click on the link for template parameters to use.
This article was last edited by Whispyhistory (talk | contribs) 4 years ago. (Update timer) |
David Livermore is professor of medical microbiology at the University of East Anglia.[1]
After working at the London Hospital Medical College from 1980 to 1997, he joined the Public Health Laboratory Service (later PHE), and became director of its Antibiotic Resistance Monitoring and Reference Laboratory. He was appointed professor of medical microbiology at the University of East Anglia in 2011. His chief research has been on the evolution and epidemiology of antibiotic resistance.[2][3]
References
- ^ Livermore, David (10 October 2020). "Protect the elderly, but let's see life back to normal for those at low risk". Daily Telegraph. Retrieved 11 October 2020.
- ^ "Professor David Livermore". British Society for Antimicrobial Chemotherapy. Retrieved 11 October 2020.
- ^ Rumbaugh, Kendra P.; Ahmad, Iqbal (2014). Antibiofilm Agents: From Diagnosis to Treatment and Prevention. Springer Science & Business Media. p. 473. ISBN 978-3-642-53832-2.
External links
 | This biographical article is a stub. You can help Wikipedia by expanding it. |